Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
| Role | Insider | Date | Transaction | Value | Shares |
|---|---|---|---|---|---|
| Director | Vieser Jaime | Jun 24, 2025 | Buy | $1.12K | 250 |
| Director | Postma Robert W | Jun 24, 2025 | Buy | $2.69K | 600 |
| Director | Postma Robert W | Apr 11, 2025 | Buy | $1.38K | 500 |
| Director | Postma Robert W | Apr 11, 2025 | Buy | $1.38K | 500 |
| Director | Vieser Jaime | Dec 31, 2024 | Sell | $4.39K | 2,182 |
| Director | Vieser Jaime | Dec 31, 2024 | Sell | $1.64K | 818 |
| CEO | Boyle Kevin S. Sr. | Sep 1, 2023 | Sell | $9.54K | 68,014 |
| Director | Vieser Jaime | Nov 29, 2022 | Buy | $812.5K | 1,250,000 |
| Director | Postma Robert W | Nov 29, 2022 | Buy | $487.5K | 750,000 |
| EVP, Operations | De Groot Eleanor | Dec 22, 2021 | Sell | $25.57K | 20,132 |
| CEO | Boyle Kevin S. Sr. | Nov 17, 2021 | Buy | $12.76K | 9,116 |
| CEO | Boyle Kevin S. Sr. | Nov 16, 2021 | Buy | $1.24K | 884 |
| Director | Vieser Jaime | Sep 29, 2021 | Buy | $191K | 100,000 |
| Director | Postma Robert W | Sep 2, 2021 | Buy | $35.48K | 20,508 |
| Director | Hagen Heidi | Sep 2, 2021 | Buy | $41.84K | 23,770 |
| Director | Postma Robert W | Sep 2, 2021 | Buy | $94.27K | 54,492 |
| Director | Huang James | Sep 1, 2021 | Buy | $171K | 100,000 |
| Director | Weis Holger | Sep 1, 2021 | Buy | $91.5K | 50,000 |
| SVP, Treasurer & CAO | Lafond Kevin G | Jan 8, 2021 | Sell | $55.68K | 18,020 |
| General Counsel and Secretary | Hadfield Robert | Jan 8, 2021 | Sell | $82.68K | 26,500 |
| EVP, GM Gene Therapy | Buck Jill | Jan 8, 2021 | Sell | $87.03K | 27,894 |
| CEO | Cooper Laurence James Neil | Jan 4, 2021 | Sell | $286.43K | 105,693 |
| EVP, GM Cell Therapy | De Groot Eleanor | Jan 4, 2021 | Sell | $58.81K | 21,620 |
| EVP, GM Gene Therapy | Buck Jill | Jan 2, 2020 | Sell | $127.05K | 27,923 |
| General Counsel and Secretary | Hadfield Robert | Jan 2, 2020 | Sell | $76.68K | 16,853 |
Open-market purchases and sales reported on SEC form 4 over the last 10years. Awards, option exercises, gifts and other non-market form 4 activity are excluded. Chart markers group a day's filings by direction; the table lists each filing.